Vertex Pharmaceuticals (VRTX) Shares Issued (2009 - 2026)

Vertex Pharmaceuticals' Shares Issued history runs 18 years deep, the most recent figure standing at $27.0 million for Q1 2026.

• In Q1 2026, Shares Issued rose 61.68% year-over-year to $27.0 million; the TTM figure through Mar 2026 stood at $138.0 million (up 20.63% YoY), while the FY2025 annual figure was $127.7 million, up 11.43% from the prior year.
• Shares Issued was $27.0 million for Q1 2026 at Vertex Pharmaceuticals, down from $54.0 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $64.4 million in Q2 2022 to a low of $7.9 million in Q3 2025.
• Historically, Shares Issued has averaged $34.7 million across 5 years, with a median of $34.3 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Issued soared 165.22% in 2022, then sank 57.92% in 2023.
• A 5-year view of Shares Issued shows it stood at $51.6 million in 2022, then dropped by 10.08% to $46.4 million in 2023, then fell by 26.08% to $34.3 million in 2024, then surged by 57.43% to $54.0 million in 2025, then tumbled by 50.0% to $27.0 million in 2026.
• The last three Shares Issued figures came in at $27.0 million (Q1 2026), $54.0 million (Q4 2025), and $7.9 million (Q3 2025), per Business Quant data.